
Robert A. Wax
Supervisory Patent Examiner (ID: 6291, Phone: (571)272-0623 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1653, 1805, 1507, 1506, 1814, 1615, 1105, 1652, 1808, 1656, 1807 |
| Total Applications | 1615 |
| Issued Applications | 927 |
| Pending Applications | 419 |
| Abandoned Applications | 277 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 446290
[patent_doc_number] => 07253147
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-08-07
[patent_title] => 'Modified serum albumin with reduced affinity for nickel and copper'
[patent_app_type] => utility
[patent_app_number] => 10/934401
[patent_app_country] => US
[patent_app_date] => 2004-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4923
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/253/07253147.pdf
[firstpage_image] =>[orig_patent_app_number] => 10934401
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/934401 | Modified serum albumin with reduced affinity for nickel and copper | Sep 6, 2004 | Issued |
Array
(
[id] => 7126960
[patent_doc_number] => 20050058704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-03-17
[patent_title] => 'Capsule containing active substance pellets'
[patent_app_type] => utility
[patent_app_number] => 10/932839
[patent_app_country] => US
[patent_app_date] => 2004-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 5130
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20050058704.pdf
[firstpage_image] =>[orig_patent_app_number] => 10932839
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/932839 | Capsule containing active substance pellets | Sep 1, 2004 | Abandoned |
Array
(
[id] => 466936
[patent_doc_number] => 07235381
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-06-26
[patent_title] => 'Expressed sequence tags and encoded human proteins'
[patent_app_type] => utility
[patent_app_number] => 10/926683
[patent_app_country] => US
[patent_app_date] => 2004-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 63931
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/235/07235381.pdf
[firstpage_image] =>[orig_patent_app_number] => 10926683
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/926683 | Expressed sequence tags and encoded human proteins | Aug 24, 2004 | Issued |
| 90/007179 | HUMAN SEL-10 POLYPEPTIDES AND POLYNUCLEOTIDES THAT ENCODE THEM | Aug 22, 2004 | Issued |
Array
(
[id] => 7025424
[patent_doc_number] => 20050019818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-27
[patent_title] => 'Human TBX20 gene and uses'
[patent_app_type] => utility
[patent_app_number] => 10/921807
[patent_app_country] => US
[patent_app_date] => 2004-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17884
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20050019818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10921807
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/921807 | Human TBX20 gene and uses | Aug 19, 2004 | Abandoned |
Array
(
[id] => 7061086
[patent_doc_number] => 20050003447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-01-06
[patent_title] => 'Human cytoskeleton associated proteins'
[patent_app_type] => utility
[patent_app_number] => 10/921707
[patent_app_country] => US
[patent_app_date] => 2004-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28547
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20050003447.pdf
[firstpage_image] =>[orig_patent_app_number] => 10921707
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/921707 | Human cytoskeleton associated proteins | Aug 18, 2004 | Abandoned |
Array
(
[id] => 7433838
[patent_doc_number] => 20040266660
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-30
[patent_title] => 'Hdl for the treatment of stroke and other ischemic conditions'
[patent_app_type] => new
[patent_app_number] => 10/487224
[patent_app_country] => US
[patent_app_date] => 2004-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4303
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20040266660.pdf
[firstpage_image] =>[orig_patent_app_number] => 10487224
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/487224 | Hdl for the treatment of stroke and other ischemic conditions | Aug 1, 2004 | Abandoned |
Array
(
[id] => 663844
[patent_doc_number] => 07102059
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-09-05
[patent_title] => 'DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses'
[patent_app_type] => utility
[patent_app_number] => 10/893776
[patent_app_country] => US
[patent_app_date] => 2004-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 25
[patent_no_of_words] => 43246
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/102/07102059.pdf
[firstpage_image] =>[orig_patent_app_number] => 10893776
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/893776 | DNA molecules and polypeptides of Pseudomonas syringae Hrp pathogenicity island and their uses | Jul 15, 2004 | Issued |
Array
(
[id] => 543131
[patent_doc_number] => 07163805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-01-16
[patent_title] => 'Human serum albumin-TIMP2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein'
[patent_app_type] => utility
[patent_app_number] => 10/888887
[patent_app_country] => US
[patent_app_date] => 2004-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 6461
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/163/07163805.pdf
[firstpage_image] =>[orig_patent_app_number] => 10888887
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/888887 | Human serum albumin-TIMP2 fusion protein, a polynucleotide encoding the same and a method of producing the human serum albumin-TIMP2 fusion protein | Jul 7, 2004 | Issued |
Array
(
[id] => 5738989
[patent_doc_number] => 20060009380
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-12
[patent_title] => 'Isolated polypeptide of the stratum corneum and its use'
[patent_app_type] => utility
[patent_app_number] => 10/879056
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6672
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0009/20060009380.pdf
[firstpage_image] =>[orig_patent_app_number] => 10879056
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/879056 | Isolated polypeptide of the stratum corneum and its use | Jun 29, 2004 | Issued |
Array
(
[id] => 6918708
[patent_doc_number] => 20050096269
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-05
[patent_title] => 'Protein Cluster II'
[patent_app_type] => utility
[patent_app_number] => 10/881528
[patent_app_country] => US
[patent_app_date] => 2004-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4991
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20050096269.pdf
[firstpage_image] =>[orig_patent_app_number] => 10881528
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/881528 | Protein Cluster II | Jun 29, 2004 | Abandoned |
Array
(
[id] => 963552
[patent_doc_number] => 06949364
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-27
[patent_title] => 'Testis-specific differentiation-regulatory factor'
[patent_app_type] => utility
[patent_app_number] => 10/876841
[patent_app_country] => US
[patent_app_date] => 2004-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6911
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/949/06949364.pdf
[firstpage_image] =>[orig_patent_app_number] => 10876841
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/876841 | Testis-specific differentiation-regulatory factor | Jun 27, 2004 | Issued |
Array
(
[id] => 7152830
[patent_doc_number] => 20050025824
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-02-03
[patent_title] => 'Pulsatile release histamine H2 antagonist dosage form'
[patent_app_type] => utility
[patent_app_number] => 10/875627
[patent_app_country] => US
[patent_app_date] => 2004-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 103
[patent_figures_cnt] => 103
[patent_no_of_words] => 11746
[patent_no_of_claims] => 84
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20050025824.pdf
[firstpage_image] =>[orig_patent_app_number] => 10875627
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/875627 | Pulsatile release histamine H2 antagonist dosage form | Jun 24, 2004 | Abandoned |
Array
(
[id] => 7334091
[patent_doc_number] => 20040255351
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-16
[patent_title] => 'Rad50 polypeptides'
[patent_app_type] => new
[patent_app_number] => 10/870507
[patent_app_country] => US
[patent_app_date] => 2004-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24514
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0255/20040255351.pdf
[firstpage_image] =>[orig_patent_app_number] => 10870507
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/870507 | Rad50 polypeptides | Jun 16, 2004 | Abandoned |
Array
(
[id] => 968288
[patent_doc_number] => 06939562
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-09-06
[patent_title] => 'Collagen/polysaccharide bilayer matrix'
[patent_app_type] => utility
[patent_app_number] => 10/868043
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4607
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/939/06939562.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868043
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868043 | Collagen/polysaccharide bilayer matrix | Jun 13, 2004 | Issued |
Array
(
[id] => 1012433
[patent_doc_number] => 06896904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-24
[patent_title] => 'Collagen/polysaccharide bilayer matrix'
[patent_app_type] => utility
[patent_app_number] => 10/868041
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4567
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/896/06896904.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868041
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868041 | Collagen/polysaccharide bilayer matrix | Jun 13, 2004 | Issued |
Array
(
[id] => 971891
[patent_doc_number] => 06936276
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-08-30
[patent_title] => 'Collagen/polysaccharide bilayer matrix'
[patent_app_type] => utility
[patent_app_number] => 10/868046
[patent_app_country] => US
[patent_app_date] => 2004-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4604
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/936/06936276.pdf
[firstpage_image] =>[orig_patent_app_number] => 10868046
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/868046 | Collagen/polysaccharide bilayer matrix | Jun 13, 2004 | Issued |
Array
(
[id] => 7252227
[patent_doc_number] => 20040259175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Human prostate cancer candidate protein 1'
[patent_app_type] => new
[patent_app_number] => 10/498462
[patent_app_country] => US
[patent_app_date] => 2004-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 38365
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259175.pdf
[firstpage_image] =>[orig_patent_app_number] => 10498462
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/498462 | Human prostate cancer candidate protein 1 | Jun 9, 2004 | Abandoned |
Array
(
[id] => 7316684
[patent_doc_number] => 20040223957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-11
[patent_title] => 'Compositions, methods and apparatuses for preserving platelets'
[patent_app_type] => new
[patent_app_number] => 10/865292
[patent_app_country] => US
[patent_app_date] => 2004-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8104
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 3
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0223/20040223957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10865292
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/865292 | Compositions, methods and apparatuses for preserving platelets | Jun 8, 2004 | Issued |
Array
(
[id] => 7351078
[patent_doc_number] => 20040248775
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-09
[patent_title] => 'Methods for screening inhibitors of apoptosis'
[patent_app_type] => new
[patent_app_number] => 10/860761
[patent_app_country] => US
[patent_app_date] => 2004-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 23874
[patent_no_of_claims] => 116
[patent_no_of_ind_claims] => 54
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0248/20040248775.pdf
[firstpage_image] =>[orig_patent_app_number] => 10860761
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/860761 | Methods for screening inhibitors of apoptosis | Jun 2, 2004 | Abandoned |